HIGH-VOLUME · FEMALE-LED
celecoxib Side Effects
celecoxib (also sold as Celebrex) is HIGH-VOLUME in this FAERS book #57 of 524 by FAERS report count. Signature opener: FEMALE-LED - 70% of sex-coded reports are female (83,065 F / 35,001 M).
Data updated 2026-05-15
- 128,099
- FAERS reports
FAERS voluntary reports, 2003 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
celecoxib reporting skew - 70% of sex-coded reports are female (83,065 F / 35,001 M). Volume band HIGH-VOLUME #57 of 524 by FAERS report count; caseload MEGA-CASE.
High-report extract for celecoxib (Celebrex): 128,099 FAERS rows (2003-2025). Top named reactions: PAIN, ARTHRALGIA, FATIGUE. Outcome stamps DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2003–2025). Stamps MEGA-CASE · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
PAIN leads 12,294 of 128,099 reports
FEMALE-LED reporters · age peak 45-64
Female-led reporters (70% of sex-coded rows)
Age peak 45-64 (33,257 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (11,737 reports, 9.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 2,402 |
| FATIGUE | 1,849 |
| HYPERTENSION | 1,686 |
| VOMITING | 1,678 |
| ARTHRALGIA | 1,619 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 1,615 |
| HYPOAESTHESIA | 1,600 |
| DIARRHOEA | 1,534 |
| GLOSSODYNIA | 1,530 |
| SYSTEMIC LUPUS ERYTHEMATOSUS | 1,529 |
| FOLLICULITIS | 1,518 |
| TYPE 2 DIABETES MELLITUS | 1,515 |
| DYSPNOEA | 1,514 |
| RHEUMATOID ARTHRITIS | 1,512 |
| HAND DEFORMITY | 1,510 |
| DIZZINESS | 1,498 |
| PAIN | 1,497 |
| ASTHENIA | 1,494 |
| DUODENAL ULCER PERFORATION | 1,487 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (39,327, 30.7% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| MYOCARDIAL INFARCTION | 4,468 |
| PAIN | 4,350 |
| ARTHRALGIA | 3,914 |
| FATIGUE | 3,879 |
| NAUSEA | 3,575 |
| DYSPNOEA | 3,153 |
| DIARRHOEA | 3,143 |
| HYPERTENSION | 2,990 |
| VOMITING | 2,983 |
| HEADACHE | 2,897 |
| RHEUMATOID ARTHRITIS | 2,863 |
| CEREBROVASCULAR ACCIDENT | 2,831 |
| MALAISE | 2,792 |
| PNEUMONIA | 2,767 |
| CONDITION AGGRAVATED | 2,693 |
| RASH | 2,664 |
| JOINT SWELLING | 2,627 |
| ASTHENIA | 2,581 |
How to read celecoxib FAERS figures (MEGA-CASE · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 128,099 voluntary reports linked to celecoxib (Celebrex), 2003-2025. Death is listed on 11,737 (9.2%). Hospitalization appears on 39,327 (30.7%). Top co-reported indication: Product Used For Unknown Indication.
MEGA-CASE books overweight common drugs and loud reporting cultures; FEMALE-LED is the page opener, not a per-patient risk.
Read with celecoxib
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 127,698 FAERS cases (Δ 401 lighter vs celecoxib); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 127,196 FAERS cases (Δ 903 lighter vs celecoxib); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 129,958 FAERS cases (Δ 1,859 heavier vs celecoxib); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 130,791 FAERS cases (Δ 2,692 heavier vs celecoxib); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's MEGA-CASE · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 52.9 pp vs celecoxib's DEATH-HEAVY): CASELOAD · HOSP-MID.
celecoxib stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload MEGA-CASE and the label guide.